Adocia announces its phase III development program for the treatment of diabetic foot ulcer. This program has been validated by scientific advice from the European Medicines Agency

Adocia Logo

Advancing Mealtime Insulin Therapy:
Phase 3 Results for BC Lispro in Type 2 Diabetes

Tuesday, June 16, 2026 | 10:00 AM ET / 4:00 PM CET

Click Here to Register & Attend